Evidence map›Paper›PMID 17018822›Full record

ArticleAmerican journal of public health2006

Investments in cancer genomics: who benefits and who decides.

Morris W Foster, John J Mulvihill, Richard R Sharp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of public health, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Best practices in nutrition science to earn and keep the public's trust.The American journal of clinical nutrition · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Morris W FosterCenter for Applied Social Research, the Cancer Institute, and University of Oklahoma, Norman 73019, USA. morris.w.foster-1@ou.edu
John J Mulvihill
Richard R Sharp

Funding

University of Oklahoma Community Networks Project OUCNPU01CA114626 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CAMPBELL, JANIS E · 2005 to 2010
$2.8M
AFRICAN AMERICAN COMMUNITY REVIEW OF GENETIC RESEARCHR01ES011174 · NIEHS · UNIVERSITY OF OKLAHOMA NORMAN · PI FOSTER, MORRIS W · 2001 to 2005
$2.6M
Community Consultation as an Ethics MethodR01HG003042 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI OSSORIO, PILAR N · 2004 to 2006
$1.0M
Indian and Hindu Perspectives on Genetic VariationP41HG003083 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI BELMONT, JOHN WILLIAM · 2004 to 2006
$961k
African-American Haplotype Map Engagement and Follow-upP41HG002691 · NHGRI · UNIVERSITY OF OKLAHOMA NORMAN · PI FOSTER, MORRIS W · 2002 to 2004
$318k
NCI NIH HHS CA114626-01NCI NIH HHS U01 CA114626NHGRI NIH HHS HG02691NHGRI NIH HHS HG03042NHGRI NIH HHS HG03083NHGRI NIH HHS P41 HG002691NHGRI NIH HHS P41 HG003083NHGRI NIH HHS R01 HG003042NIEHS NIH HHS ES11174NIEHS NIH HHS R01 ES011174
6 · The paper itself

Abstract

The Cancer Genome Atlas--formerly the Human Cancer Genome Project--provides an opportunity for considering how social concerns about resource allocation are interrelated with practical decisions about specific research strategies--part of a continuing convergence between scientific and public evaluations of priorities for biomedical research funding. For example, the manner, order, and extent that The Cancer Genome Atlas selects tumor types and populations to be sampled will determine who benefits most from its findings. Those choices will be determined on the basis of both scientific and social values. By soliciting public involvement and conducting rigorous policy analysis in the design of large scientific projects such as The Cancer Genome Atlas, cancer researchers can help democratize the allocation of scientific resources and foster public confidence in biomedical research.

Indexed as

Community ParticipationDecision Making, OrganizationalInvestmentsPolicy MakingResearch Support as TopicSocial ValuesAtlases as TopicDemocracyHuman Genome ProjectHumansPatient AdvocacyRare DiseasesResearchResource AllocationSocial JusticeUnited States

Identifiers

PMID17018822
PMCPMC1751797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.